by PEPID Newsroom | Oct 2, 2018 | Alerts
The FDA approved cemiplimab-rwlc (Libtayo) for treatment of locally advanced, or metastatic, cutaneous squamous cell carcinoma (CSCC). This is the first drug treatment approved for advanced CSCC, the second most common cancer in the U.S. Please see the FDA website for...
by PEPID Newsroom | Aug 17, 2018 | Alerts
The FDA has approved the first generic version of Mylan’s EpiPEN and EpiPen Jr (epinephrine) auto injector used to treat emergency allergic reactions, such as the life-threatening anaphylaxis. The generic epinephrine auto-injector has been green flagged to market in...
by PEPID Newsroom | Aug 16, 2018 | Alerts
The U.S. FDA approved the first of its kind targeted RNA-based therapy Onpattro (patisiran) to treat peripheral nerve disease (polyneuropathy) caused from hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA approved treatment...
by PEPID Newsroom | Aug 13, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care
Following the Centers for Medicare & Medicaid Services’ (CMS) April 2018 rule proposal announcement, comes the finalization of the “Promoting Interoperability” rule (PI, formerly known as the Meaningful Use program, or Medicare and Medicaid EHR Incentive Program)....
by PEPID Newsroom | Aug 3, 2018 | Emergency Medicine, Nursing, Pharmacy, Primary Care, Uncategorized
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage breastfeeding,...
